Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Over 4,000 beagles destined for drug experiments finding new homes

Published 08/09/2022, 05:21 PM
Updated 08/09/2022, 07:20 PM

(Reuters) - About 4,000 beagles are looking for homes after animal rescue organizations started removing them from a Virginia facility that bred them to be sold to laboratories for drug experiments.

"It's going to take 60 days to get all of these animals out, and working with our shelter and rescue partners across the country, working with them to get these dogs into eventually into ever-loving home," said Kitty Block, president and chief executive of the U.S. Humane Society.

Shelters from South Elgin, Illinois, to Pittsburgh have begun receiving the dogs, which will get medical exams, vaccinations and other treatments before becoming available for adoption.

In May, the U.S. Department of Justice sued Envigo RMS LLC alleging Animal Welfare Act violations at the facility in Cumberland, Virginia. In June, parent company Inotiv Inc said it would close the facility. In July, Envigo settled with the government, without paying any fines.

Inotiv did not respond to a request for comment.

Government inspectors found beagles there were being killed instead of receiving care for easily treated conditions; nursing mother beagles were denied food; the food they received contained maggots, mold and feces; and over an eight-week period, 25 beagle puppies died from cold exposure, the Humane Society said in a statement. Some were injured when attacked by other dogs in overcrowded conditions, it added.

The beagle rescue effort began much earlier, according Bill Stanley, a Republican state senator for Virginia. "I tried to shut them down in 2019, but was not successful. But over the years, we never stopped fighting."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.